Intellia Therapeutics is seeking FDA approval for its drug Lonvo-Z.

1 report, 1 independent Updated Sep 8

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

FDA Intellia Therapeutics

Keep exploring

Part of

The FDA and Intellia Therapeutics are preparing a regulatory filing for product approval. All 2 developments

The entities involved

FDA
- Sanofi, Regeneron, and Bayer are involved in new market developments, including FDA submissions regarding eczema and eye care treatments.17:04
- FDA approval is the goal for product candidates from Daré Bioscience, Inc.14:49
Intellia Therapeutics
It is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system.
- Intellia Therapeutics and Neurogene are identified as small-cap healthcare companies.Sat 08:13

Related events

Coverage

Newest first; wire copies grouped

Sep 8manilatimes.net